title: Community-based epidemiological study of glucose tolerance in Kin-Chen, Kinmen: support for a new intermediate classification.
abstract: In this population-based survey, we investigated the prevalence of varying degrees of glucose tolerance among residents of Kin-Chen, Kinmen, as well as the association of glucose tolerance status with potential risk factors for type 2 diabetes and cardiovascular disease (CVD). We focused particularly on subjects with normal 2-h postload glucose level (<7.8 mmol/l) but persistent fasting hyperglycemia (PFH) (5.6-7.8 mmol/l), to examine whether PFH represents an intermediate state between normal glucose tolerance (NGT) and impaired glucose tolerance (IGT). The target population comprised 6346 residents aged 30 years and older. A total of 4354 subjects could be classified into categories of NGT, PFH, IGT, new diabetes, and known diabetes according to medical history, fasting plasma glucose levels, and the results of a 75-g oral glucose tolerance test (OGTT). The potential cardiovascular risk factors assessed included age, obesity (general and central), systolic blood pressure, and fasting levels of insulin, C-peptide, triglyceride, cholesterol, and high-density lipoprotein cholesterol (HDL-C). The age-standardized prevalences of PFH, IGT, new diabetes, and known diabetes were 2.9%, 3.5%, 4.0%, and 3.0%, respectively. Among nondiabetic subjects, the cardiovascular risk factor profiles worsened with decreasing glucose tolerance, with most values differing significantly among the NGT, PFH, and IGT groups. Subjects with PFH, who would be classified as having NGT according to conventional WHO criteria, had physical and biochemical features between those of the NGT and IGT groups. These findings support our previous observation that PFH may be a transition state between NGT and IGT in the progression toward type 2 diabetes.
authors.affiliation: Department of Medicine, Veterans General Hospital-Taipei, Taipei, Taiwan.
authors.forename: S T
authors.initials: ST
authors.lastname: Tsai
authors.forename: C L
authors.initials: CL
authors.lastname: Li
authors.forename: C H
authors.initials: CH
authors.lastname: Chen
authors.forename: P
authors.initials: P
authors.lastname: Chou
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D002096:C-Peptide / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology*; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D013624:Taiwan / Q000453:epidemiology
chemical_list: D002096:C-Peptide; D007328:Insulin